BSX - Boston Scientific Corp
119
$71.28
$0.08 (0.112%)
At market close
$71.22
-$0.06 (-0.090%)
After Hours 3/18/26, 9:31 PM
Score4.04/5
Price Targets
These are one year price targets for: 2027-02-21
High:
$130.20
82.7%
Avg:
$107.13
50.3%
Low:
$83.83
17.6%
% change is relative to the current stock price ($71.28).
Most Recent Recommendations
4.28
Very Good
35%
Strong Buy (14)
57%
Buy (23)
8%
Hold (3)
0%
Sell (0)
0%
Strong Sell (0)
Revenue Estimate
- Past Revenue
- Avg
- High
- Low
EPS Estimate
- Past EPS
- Avg
- High
- Low
Revenue Estimate as % change
YoY is the % change of each analyst estimate, relative to the prior year
| 2026 | 2027 | 2028 | 2029 | 2030 | |
|---|---|---|---|---|---|
| Low | 10.5% | 9.35% | 8.95% | 12.0% | 11.7% |
| Avg | 10.9% | 10.5% | 10.2% | 9.89% | 10.8% |
| High | 12.7% | 10.7% | 8.77% | 9.73% | 10.0% |
EPS Estimate as % change
YoY is the % change of each analyst estimate, relative to the prior year
| 2026 | 2027 | 2028 | 2029 | 2030 | |
|---|---|---|---|---|---|
| Low | 14.8% | 10.5% | 4.50% | 17.2% | 19.2% |
| Avg | 14.1% | 13.2% | 12.1% | 12.1% | 13.5% |
| High | 14.4% | 14.6% | 14.5% | 10.0% | 12.5% |
Recommendation Trends
- Strong Sells
- Sells
- Holds
- Buys
- Strong Buys
Latest Analyst Ratings
Institution | Action | Grade | Old Grade | Date |
|---|---|---|---|---|
| UBS | Maintain | Buy | Buy | 2026-03-17 |
| Citigroup | Maintain | Buy | Buy | 2026-03-11 |
| Canaccord Genuity | Maintain | Buy | Buy | 2026-02-17 |
| BTIG | Maintain | Buy | Buy | 2026-02-09 |
| Canaccord Genuity | Maintain | Buy | Buy | 2026-02-05 |
| RBC Capital | Maintain | Outperform | Outperform | 2026-02-05 |
| UBS | Maintain | Buy | Buy | 2026-02-05 |
| TD Cowen | Maintain | Buy | Buy | 2026-02-05 |
| JP Morgan | Maintain | Overweight | Overweight | 2026-02-05 |
| Citigroup | Maintain | Buy | Buy | 2026-02-05 |